It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
originally posted by: Phantom423
a reply to: AaarghZombies
I don't know where you learned biology, but I would ask for a refund. Every comment you made is totally 100% wrong.
originally posted by: Flatcoat
I have to dispute that I'm afraid. My personal experience (yes...anecdotal) is precisely the opposite. I've had it as has at least a dozen of my family and friends. The unvaxed, myself included, experienced maybe a day and a half of slight fever and sweating. The vaxed, on the other hand, were laid up for well over a week, and some are still experiencing difficulties.
originally posted by: Phantom423
a reply to: AaarghZombies
What's the patent number. I'll look it up. I think you made that up.
originally posted by: CptGreenTea
a reply to: v1rtu0s0
What are his credentials beyond being a vetenarian and working with the bill gates foundation?
Also, has he addressed other doctor's criticisms of his 44 or so page claims?
Its not peer reviewed so shoukdn't he have a FAQ to address criticism?
Cant just take it at face value because he had a job with bill gates..
originally posted by: CptGreenTea
a reply to: v1rtu0s0
What are his credentials
Geert Vanden Bossche, PhD, DVM
Managing Director VARECO Sep 2012 - 2019 Europe Independent vaccine consultant with a long- standing track record in Academia, Vaccine Industry and Global Health
Head of the Vaccine Development Office
German Centre for Infection Research (DZIF
Aug 2017 - Dec 2017
Cologne, Germany
Spearheading a portfolio of translational vaccine research projects
Chief Innovation & Scientific Officer
Univac
Nov 2014 - Nov 2016
Huldenberg II founded Univac as inventor of a new vaccine technology
Program Manager
Global Alliance for Vaccines and Immunization (GAVI)
Mar 2015 - Mar 2016
Geneva Area, Switzerland
During my term at GAVI, I coordinated GAVI’s Ebola Vaccine Program and contributed
to the implementation of an integrated vaccine work plan in collaboration with Global
Health Partners (WHO, Bill & Melinda Gates Foundation, CDC, UNICEF), regulators (FDA)
DVM, PhD, adjunct professor
Positions in Academia
Sep 1980 - Sep 2015
Belgium - Germany
Training in Veterinary Medicine at the faculty Notre-Dame-de-la-Paix and the State
University of
Ghent (1980-1983)
- Doctoral degree in Veterinary Medicine from State University of Ghent (1983)
- Postdoctoral training in Equine Medicine and Surgery at the Free University of Berlin,
Germany
(1984-1987)
- Postdoctoral Fellowship in Virology at James A. Baker Institute for Animal Health,
Cornell
University, Ithaca, NY
Senior Program Officer, Global Health, Vaccine Discovery
Bill & Melinda Gates Foundation (BMGF)
May 2008 - Jun 2011
Seattle, Washington 98102, USA
Responsible for operating Vaccine Programs (e.g., HIV-1, Malaria, TB, Polio
Global Project Director Influenza Vaccines
Solvay Biologicals
Jul 2007 - May 2008
Weesp, the Netherlands
Director, Research Program Leader and Head of Adjuvants
Novartis Vaccines & Diagnostics
Aug 2006 - Jul 2007
Siena, Italy & Emeryville, USA
Vaccine Research Program/Adjuvant Program responsibilities:
- Project leader of NVD's RSV vaccine project (Respiratory Syncytial Virus)...
Head of Adjuvant Technologies and Alternative Deliveries, R&D
GlaxoSmithKline Biologicals
May 2001 - May 2006
Rixensart, Belgium
- Research Program Leader on Vaccine Formulation Development & Alternative
Deliveries
GSK Biologicals
o Senior Project Leader ‘Adolescent Vaccine Projects'
Jun 1998 - May 2001
Rixensart, Belgium
Major responsibilities:
Project Management on Raw Material Traceability (RAMATRA) and vaccine projects in
Late Development, e.g., Herpes Simplex Virus type 2, Hepatitis B, Streptococcus
Pneumoniae and Enterotoxic Escherichia Coli (in collaboration with SBL Vaccines,
Sweden)
New Biotech Vaccine Development and QC-QA Manager
Feb 1995 - May 1998
Rixensart, Belgium
olis.oregonlegislature.gov...
The infections may be mild to moderate now, but as the virus selects stronger variants, there is a real possibility that a lethal variant may be selected.
You're thinking of Bacteria, virus can't do this. Covid cannot make environmental selections, it lacks the biological hardware to do this.
Rapid mutation allows the virus to pick and choose which variant works best for its survival.
Only on the TV, in real life virus can't do this, they mutate as they replicate, and they don't have any element of self selection. The don't even do it in response to external stimuli. You're thinking of bacteria. Virus aren't complex enough to do this. At least Coronavirus isn't.